Controlled drug delivery in tissue engineering

Advanced Drug Delivery Reviews

Volumn 60, Issue 2, 2008, Pages 229-242

  Biondi, Marco ^a   Ungaro, Francesca ^a   Quaglia, Fabiana ^a   Netti, Paolo Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

basic fibroblast growth factor; bFGF; Biomaterials; BMP; bone morphogenetic protein; bovine serum albumin; BSA; CASD; computer aided scaffold design; delivery systems; Drug delivery; DS; ECM; EGF; epidermal growth factor; ethylene vinyl acetate copolymers; EVAc; extracellular matrix; GF; growth factor; Growth factors; HBDS; heparin based delivery systems; neurotrophin 3; NT 3; PA; parathyroid hormone; PCL; PDGF; PEG; PEO; peptide amphiphile; PLA; platelet derived growth factor; PLGA; POE; poly(ethylene glycol); poly(ethylene oxide); poly(e open caprolactone); poly(lactide); poly(lactide co glycolide); poly(ortho esters); PTH; Scaffold; SFF; solid free form fabrication; TE; TGF 1; Tissue engineering; tissue engineering; transforming growth factor beta1; vascular endothelial growth factor; VEGF

Indexed keywords

PARATHYROID HORMONES; POLY(LACTIDE-CO-GLYCOLIDE); POLY(ORTHO ESTERS); SOLID FREE-FORM FABRICATION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANGIOGRAPHY; BIOMATERIALS; CELL CULTURE; GROWTH KINETICS; HORMONES; MOLECULAR BIOLOGY; TISSUE ENGINEERING;

DRUG DELIVERY;

ALGINIC ACID; ARGINYLGLYCYLASPARTIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CHITOSAN; COLLAGEN; ELASTIN; EPIDERMAL GROWTH FACTOR; FIBRIN; FIBRONECTIN; GELATIN; GROWTH FACTOR; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYDROXYAPATITE; LAMININ; MACROGOL; NEUROTROPHIN 3; PLATELET DERIVED GROWTH FACTOR; POLY(ETHYLENE GLYCOL)FUMARATE; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIBODY SPECIFICITY; BONE REMODELING; CELL DIFFERENTIATION; CELL FUNCTION; DRUG DELIVERY SYSTEM; ENGINEERING; EXTRACELLULAR MATRIX; IN VIVO STUDY; MICROENVIRONMENT; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; SYMBIOSIS; TECHNOLOGY; TISSUE ENGINEERING; TISSUE SPECIFICITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; DELAYED-ACTION PREPARATIONS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 36849020930     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.08.038     Document Type: Review

References (176)

1. Lavik E., and Langer R. Tissue engineering: current state and perspectives. Appl. Microbiol. Biotechnol. 65 (2004) 1-8
2. Mikos A.G., Herring S.W., Ochareon P., Elisseeff J., Lu H.H., Kandel R., Schoen F.J., Toner M., Mooney D., Atala A., Van Dyke M.E., Kaplan D., and Vunjak-Novakovic G. Engineering complex tissues. Tissue Eng. 12 (2006) 3307-3339
3. Niklason L.E., and Langer R. Prospects for organ and tissue replacement. JAMA. 285 (2001) 573-576
4. Goldberg M., Langer R., and Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J. Biomater. Sci. Polym. Ed. 18 (2007) 241-268
5. Matsumoto T., and Mooney D.J. Cell instructive polymers. Adv. Biochem. Eng Biotechnol. 102 113-37 (2006) 113-137
6. Hutmacher D.W. Scaffold design and fabrication technologies for engineering tissues-state of the art and future perspectives. J. Biomater. Sci. Polym. Ed. 12 (2001) 107-124
7. Tabata Y. Significance of release technology in tissue engineering. Drug Discov. Today. 10 (2005) 1639-1646
8. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23 (2005) 47-55
9. Sachlos E., and Czernuszka J.T. Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur. Cell Mater. 5 (2003) 29-39
10. Sun W., Darling A., Starly B., and Nam J. Computer-aided tissue engineering: overview, scope and challenges. Biotechnol. Appl. Biochem. 39 (2004) 29-47
11. Boland T., Xu T., Damon B., and Cui X. Application of inkjet printing to tissue engineering. Biotechnol. J. 1 (2006) 910-917
12. Teo W.E., He W., and Ramakrishna S. Electrospun scaffold tailored for tissue-specific extracellular matrix. Biotechnol. J. 1 (2006) 918-929
13. Guarino V., Causa F., and Ambrosio L. Bioactive scaffolds for bone and ligament tissue. Expert. Rev. Med. Devices. 4 (2007) 405-418
14. Langer R., and Tirrell D.A. Designing materials for biology and medicine. Nature. 428 (2004) 487-492
15. Malafaya P.B., Silva G.A., and Reis R.L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev. 59 (2007) 207-233
16. Sokolsky-Papkov M., Agashi K., Olaye A., Shakesheff K., and Domb A.J. Polymer carriers for drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 59 (2007) 187-206
17. Chen R.R., and Mooney D.J. Polymeric growth factor delivery strategies for tissue engineering. Pharm. Res. 20 (2003) 1103-1112
18. Saltzman W.M., and Olbricht W.L. Building drug delivery into tissue engineering. Nat. Rev. Drug Discov. 1 (2002) 177-186
19. Tessmar J.K., and Gopferich A.M. Matrices and scaffolds for protein delivery in tissue engineering. Adv. Drug Deliv. Rev. 59 (2007) 274-291
20. Kretlow J.D., Klouda L., and Mikos A.G. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 59 (2007) 263-273
21. Zhang G., and Suggs L.J. Matrices and scaffolds for drug delivery in vascular tissue engineering. Adv. Drug Deliv. Rev. 59 (2007) 360-373
22. Lee S.H., and Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv. Drug Deliv. Rev. 59 (2007) 339-359
23. Holland T.A., and Mikos A.G. Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. Adv. Biochem. Eng Biotechnol. 102 (2006) 161-185
24. Bosman F.T., and Stamenkovic I. Functional structure and composition of the extracellular matrix. J. Pathol. 200 (2003) 423-428
25. Katz E., and Streuli C.H. The extracellular matrix as an adhesion checkpoint for mammary epithelial function. Int. J. Biochem. Cell Biol. 39 (2007) 715-726
26. Hynes R.O. Integrins: Bidirectional, allosteric signaling machines. Cell 20 110 (2002) 673-687
27. Fittkau M.H., Zilla P., Bezuidenhout D., Lutolf M.P., Human P., Hubbell J.A., and Davies N. The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. Biomaterials. 26 (2005) 167-174
28. Stupack D.G., and Cheresh D.A. ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands. Sci. STKE. 2002 (2002) E7
29. Rapraeger A.C. Syndecan-regulated receptor signaling. J. Cell Biol. 149 (2000) 995-998
30. Wijelath E.S., Murray J., Rahman S., Patel Y., Ishida A., Strand K., Aziz S., Cardona C., Hammond W.P., Savidge G.F., Rafii S., and Sobel M. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ. Res. 91 (2002) 25-31
31. Taipale J., and Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 11 (1997) 51-59
32. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 84 (1996) 345-357
33. Gurdon J.B., Harger P., Mitchell A., and Lemaire P. Activin signalling and response to a morphogen gradient. Nature. 371 (1994) 487-492
34. Tanabe Y., and Jessell T.M. Diversity and pattern in the developing spinal cord. Science. 274 (1996) 1115-1123
35. Burgess B.T., Myles J.L., and Dickinson R.B. Quantitative analysis of adhesion-mediated cell migration in three-dimensional gels of RGD-grafted collagen. Ann. Biomed. Eng. 28 (2000) 110-118
36. Kong H.J., and Mooney D.J. Microenvironmental regulation of biomacromolecular therapies. Nat. Rev. Drug Discov. 6 (2007) 455-463
37. Beniash E., Hartgerink J.D., Storrie H., Stendahl J.C., and Stupp S.I. Self-assembling peptide amphiphile nanofiber matrices for cell entrapment. Acta Biomater. 1 (2005) 387-397
38. Silva E.A., and Mooney D.J. Synthetic extracellular matrices for tissue engineering and regeneration. Curr. Top. Dev. Biol. 64 (2004) 181-205
39. Leach J.K. Multifunctional cell-instructive materials for tissue regeneration. Regen. Med. 1 (2006) 447-455
40. Salvay D.M., and Shea L.D. Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol. Biosyst. 2 (2006) 36-48
41. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., Jeltsch M., Mitchell C., Alitalo K., Shima D., and Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161 (2003) 1163-1177
42. Helm C.L., Fleury M.E., Zisch A.H., Boschetti F., and Swartz M.A. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15779-15784
43. Lee K.Y., and Mooney D.J. Hydrogels for tissue engineering. Chem. Rev. 101 (2001) 1869-1879
44. Anseth K.S., Bowman C.N., and Brannon-Peppas L. Mechanical properties of hydrogels and their experimental determination. Biomaterials. 17 (1996) 1647-1657
45. Davis K.A., and Anseth K.S. Controlled release from crosslinked degradable networks. Crit Rev. Ther. Drug Carrier Syst. 19 (2002) 385-423
46. Peppas N.A., Keys K.B., Torres-Lugo M., and Lowman A.M. Poly(ethylene glycol)-containing hydrogels in drug delivery. J. Control Release. 62 (1999) 81-87
47. Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 54 (2002) 3-12
48. Van Tomme S.R., and Hennink W.E. Biodegradable dextran hydrogels for protein delivery applications. Expert. Rev. Med. Devices. 4 (2007) 147-164
49. Bonadio J., Smiley E., Patil P., and Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5 (1999) 753-759
50. Tyrone J.W., Mogford J.E., Chandler L.A., Ma C., Xia Y., Pierce G.F., and Mustoe T.A. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J. Surg. Res. 93 (2000) 230-236
51. Cohen-Sacks H., Elazar V., Gao J., Golomb A., Adwan H., Korchov N., Levy R.J., Berger M.R., and Golomb G. Delivery and expression of pDNA embedded in collagen matrices. J. Control Release. 95 (2004) 309-320
52. Quick D.J., and Anseth K.S. DNA delivery from photocrosslinked PEG hydrogels: encapsulation efficiency, release profiles, and DNA quality. J. Control Release. 96 (2004) 341-351
53. Kasper F.K., Seidlits S.K., Tang A., Crowther R.S., Carney D.H., Barry M.A., and Mikos A.G. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. J. Control Release. 104 (2005) 521-539
54. Wieland J.A., Houchin-Ray T.L., and Shea L.D. Non-viral vector delivery from PEG-hyaluronic acid hydrogels. J. Control Release. 120 (2007) 233-241
55. Mellott M.B., Searcy K., and Pishko M.V. Release of protein from highly cross-linked hydrogels of poly(ethylene glycol) diacrylate fabricated by UV polymerization. Biomaterials. 22 (2001) 929-941
56. Temenoff J.S., Athanasiou K.A., LeBaron R.G., and Mikos A.G. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J. Biomed. Mater. Res. 59 (2002) 429-437
57. Qiu B., Stefanos S., Ma J., Lalloo A., Perry B.A., Leibowitz M.J., Sinko P.J., and Stein S. A hydrogel prepared by in situ cross-linking of a thiol-containing poly(ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. Biomaterials. 24 (2003) 11-18
58. Rizzi S.C., Ehrbar M., Halstenberg S., Raeber G.P., Schmoekel H.G., Hagenmuller H., Muller R., Weber F.E., and Hubbell J.A. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules. 7 (2006) 3019-3029
59. Grizzi I., Garreau H., Li S., and Vert M. Hydrolytic degradation of devices based on poly(dl-lactic acid) size-dependence. Biomaterials. 16 (1995) 305-311
60. Murphy W.L., Peters M.C., Kohn D.H., and Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 21 (2000) 2521-2527
61. Peters M.C., Polverini P.J., and Mooney D.J. Engineering vascular networks in porous polymer matrices. J. Biomed. Mater. Res. 60 (2002) 668-678
62. Shea L.D., Smiley E., Bonadio J., and Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17 (1999) 551-554
63. Chung H.J., and Park T.G. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv. Drug Deliv. Rev. 59 (2007) 249-262
64. Sakiyama-Elbert S.E., and Hubbell J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J. Control Release. 65 (2000) 389-402
65. Wissink M.J., Beernink R., Pieper J.S., Poot A.A., Engbers G.H., Beugeling T., van Aken W.G., and Feijen J. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials. 22 (2001) 2291-2299
66. Lee A.C., Yu V.M., Lowe III J.B., Brenner M.J., Hunter D.A., Mackinnon S.E., and Sakiyama-Elbert S.E. Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp. Neurol. 184 (2003) 295-303
67. Taylor S.J., McDonald III J.W., and Sakiyama-Elbert S.E. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J. Control Release. 98 (2004) 281-294
68. Yoon J.J., Chung H.J., Lee H.J., and Park T.G. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J. Biomed. Mater. Res. A. 79 (2006) 934-942
69. Jeon O., Song S.J., Kang S.W., Putnam A.J., and Kim B.S. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold. Biomaterials. 28 (2007) 2763-2771
70. Nillesen S.T., Geutjes P.J., Wismans R., Schalkwijk J., Daamen W.F., and van Kuppevelt T.H. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials. 28 (2007) 1123-1131
71. Kuhl P.R., and Griffith-Cima L.G. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nat. Med. 2 (1996) 1022-1027
72. Karageorgiou V., Meinel L., Hofmann S., Malhotra A., Volloch V., and Kaplan D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J. Biomed. Mater. Res. A. 71 (2004) 528-537
73. Mann B.K., Schmedlen R.H., and West J.L. Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells. Biomaterials. 22 (2001) 439-444
74. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., Schmokel H., Bezuidenhout D., Djonov V., Zilla P., and Hubbell J.A. Cell -demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J. 17 (2003) 2260-2262
75. Moore K., MacSween M., and Shoichet M. Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds. Tissue Eng. 12 (2006) 267-278
76. Dinbergs I.D., Brown L., and Edelman E.R. Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J. Biol. Chem. 271 (1996) 29822-29829
77. Ikeda Y., and Taira K. Ligand-targeted delivery of therapeutic siRNA. Pharm. Res. 23 (2006) 1631-1640
78. Boontheekul T., and Mooney D.J. Protein-based signaling systems in tissue engineering. Curr. Opin. Biotechnol. 14 (2003) 559-565
79. Huang Y.C., Kaigler D., Rice K.G., Krebsbach P.H., and Mooney D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. 20 (2005) 848-857
80. Lu Y., Shansky J., Del T.M., Ferland P., Wang X., and Vandenburgh H. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation. 104 (2001) 594-599
81. Savarino L., Baldini N., Greco M., Capitani O., Pinna S., Valentini S., Lombardo B., Esposito M.T., Pastore L., Ambrosio L., Battista S., Causa F., Zeppetelli S., Guarino V., and Netti P.A. The performance of poly-epsilon-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4. Biomaterials. 28 (2007) 3101-3109
82. Shen H., Tan J., and Saltzman W.M. Surface-mediated gene transfer from nanocomposites of controlled texture. Nat. Mater. 3 (2004) 569-574
83. Riddle K.W., Kong H.J., Leach J.K., Fischbach C., Cheung C., Anseth K.S., and Mooney D.J. Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. Mol. Ther. 15 (2007) 361-368
84. Langer R. Tissue engineering. Mol. Ther. 1 (2000) 12-15
85. van de Weert W.M., Jorgensen L., Horn M.E., and Frokjaer S. Factors of importance for a successful delivery system for proteins. Expert. Opin. Drug Deliv. 2 (2005) 1029-1037
86. Walsh W.R., Kim H.D., Jong Y.S., and Valentini R.F. Controlled release of platelet-derived growth factor using ethylene vinyl acetate copolymer (EVAc) coated on stainless-steel wires. Biomaterials. 16 (1995) 1319-1325
87. Kim H.D., and Valentini R.F. Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-beta delivered from controlled-release polymer rods. Biomaterials. 18 (1997) 1175-1184
88. Fleming A.B., and Saltzman W.M. Simultaneous delivery of an active protein and neutralizing antibody: creation of separated regions of biological activity. J. Control Release. 70 (2001) 29-36
89. Leoni L., and Desai T.A. Micromachined biocapsules for cell-based sensing and delivery. Adv. Drug Deliv. Rev. 56 (2004) 211-229
90. Brannon-Peppas L., and Vert M. Polylactic and polyglycolic acids as drug delivery carriers. In: Wise D.L. (Ed). Handbook of Pharmaceutical Controlled Release Technology (2000), Marcel Dekker, Inc., New York 99-130
91. Sinha V.R., and Trehan A. Biodegradable microspheres for protein delivery. J. Control. Release 90 (2003) 261-280
92. Lam X.M., Duenas E.T., Daugherty A.L., Levin N., and Cleland J.L. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J. Control Release. 67 (2000) 281-292
93. Lu L., Stamatas G.N., and Mikos A.G. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J. Biomed. Mater. Res. 50 (2000) 440-451
94. Pean J.M., Menei P., Morel O., Montero-Menei C.N., and Benoit J.P. Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. Biomaterials. 21 (2000) 2097-2101
95. Peter S.J., Lu L., Kim D.J., Stamatas G.N., Miller M.J., Yaszemski M.J., and Mikos A.G. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J. Biomed. Mater. Res. 50 (2000) 452-462
96. Cleland J.L., Duenas E.T., Park A., Daugherty A., Kahn J., Kowalski J., and Cuthbertson A. Development of poly-(d,l-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J. Control Release. 72 (2001) 13-24
97. Elisseeff J., McIntosh W., Fu K., Blunk B.T., and Langer R. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J. Orthop. Res. 19 (2001) 1098-1104
98. Lam X.M., Duenas E.T., and Cleland J.L. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. J. Pharm. Sci. 90 (2001) 1356-1365
99. Meinel L., Illi O.E., Zapf J., Malfanti M., Peter M.H., and Gander B. Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres. J. Control Release. 70 (2001) 193-202
100. Perets A., Baruch Y., Weisbuch F., Shoshany G., Neufeld G., and Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J. Biomed. Mater. Res. A. 65 (2003) 489-497
101. Kim T.K., and Burgess D.J. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J. Pharm. Pharmacol. 54 (2002) 897-905
102. Norton L.W., Tegnell E., Toporek S.S., and Reichert W.M. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Biomaterials. 26 (2005) 3285-3297
103. Bala I., Hariharan S., and Kumar M.N. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev. Ther. Drug Carrier Syst. 21 (2004) 387-422
104. Astete C.E., and Sabliov C.M. Synthesis and characterization of PLGA nanoparticles. J. Biomater. Sci. Polym. Ed. 17 (2006) 247-289
105. Yang A., Yang L., Liu W., Li Z., Xu H., and Yang X. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation. Int. J. Pharm. 331 (2007) 123-132
106. Packhaeuser C.B., Schnieders J., Oster C.G., and Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur. J. Pharm. Biopharm. 58 (2004) 445-455
107. Ravivarapu H.B., Moyer K.L., and Dunn R.L. Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant. AAPS. Pharm. Sci. Tech. 1 (2000) E1
108. Zentner G.M., Rathi R., Shih C., McRea J.C., Seo M.H., Oh H., Rhee B.G., Mestecky J., Moldoveanu Z., Morgan M., and Weitman S. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J. Control Release. 72 (2001) 203-215
109. Choi S., Baudys M., and Kim S.W. Control of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic rats. Pharm. Res. 21 (2004) 827-831
110. Samlowski W.E., McGregor J.R., Jurek M., Baudys M., Zentner G.M., and Fowers K.D. ReGel polymer-based delivery of interleukin-2 as a cancer treatment. J. Immunother. 29 (2006) 524-535
111. Einmahl S., Capancioni S., Schwach-Abdellaoui K., Moeller M., Behar-Cohen F., and Gurny R. Therapeutic applications of viscous and injectable poly(ortho esters). Adv. Drug Deliv. Rev. 53 (2001) 45-73
112. Heller J., Barr J., Ng S.Y., Abdellauoi K.S., and Gurny R. Poly(ortho esters): synthesis, characterization, properties and uses. Adv. Drug Deliv. Rev. 54 (2002) 1015-1039
113. Rothen-Weinhold A., Schwach-Abdellaoui K., Barr J., Ng S.Y., Shen H.R., Gurny R., and Heller J. Release of BSA from poly(ortho ester) extruded thin strands. J. Control Release. 71 (2001) 31-37
114. Heller J., Barr J., Ng S., and Shen H. Injectable Semi-Solid Poly (Ortho Esters) for the Controlled Delivery of Therapeutic Agents: Synthesis and Applications. Drug Deliv. Tech. 2 (2002)
115. van de Weert W.M., van Steenbergen M.J., Cleland J.L., Heller J., Hennink W.E., and Crommelin D.J. Semisolid, self-catalyzed poly(ortho ester)s as controlled-release systems: protein release and protein stability issues. J. Pharm. Sci. 91 (2002) 1065-1074
116. Kumar N., Langer R.S., and Domb A.J. Polyanhydrides: An overview. Adv. Drug Deliv. Rev. 54 (2002) 889-910
117. Jain J.P., Modi S., Domb A.J., and Kumar N. Role of polyanhydrides as localized drug carriers. J. Control Release. 103 (2005) 541-563
118. Tabata Y., Gutta S., and Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm. Res. 10 (1993) 487-496
119. Kipper M.J., Wilson J.H., Wannemuehler M.J., and Narasimhan B. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. J. Biomed. Mater. Res. A. 76 (2006) 798-810
120. Torres M.P., Determan A.S., Anderson G.L., Mallapragada S.K., and Narasimhan B. Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials. 28 (2007) 108-116
121. Stubbe B.G., De Smedt S.C., and Demeester J. Programmed polymeric devices for pulsed drug delivery. Pharm. Res. 21 (2004) 1732-1740
122. Kost J., and Langer R. Responsive polymeric delivery systems. Adv. Drug Deliv. Rev. 46 (2001) 125-148
123. Miyata T., Uragami T., and Nakamae K. Biomolecule-sensitive hydrogels. Adv. Drug Deliv. Rev. 54 (2002) 79-98
124. Thomasin C., Corradin G., Ying M., Merkle H.P., and Gander B. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response. J. Control Release 41 (1996) 131-145
125. Sanchez A., Gupta R.K., Alonso M.J., Siber G.R., and Langer R. Pulsed controlled-released system for potential use in vaccine delivery. J. Pharm. Sci. 85 (1996) 547-552
126. Hilbert A.K., Fritzsche U., and Kissel T. Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine. 17 (1999) 1065-1073
127. Franssen O., Stenekes R.J., and Hennink W.E. Controlled release of a model protein from enzymatically degrading dextran microspheres. J. Control Release 59 (1999) 219-228
128. Jiang W., Gupta R.K., Deshpande M.C., and Schwendeman S.P. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv. Drug Deliv. Rev. 57 (2005) 391-410
129. Liu X., Pettway G.J., McCauley L.K., and Ma P.X. Pulsatile release of parathyroid hormone from an implantable delivery system. Biomaterials 28 (2007) 4124-4131
130. Cleland J.L., Barron L., Berman P.W., Daugherty A., Gregory T., Lim A., Vennari J., Wrin T., and Powell M.F. Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response. J. Pharm. Sci. 85 (1996) 1346-1349
131. Cleland J.L., Lim A., Daugherty A., Barron L., Desjardin N., Duenas E.T., Eastman D.J., Vennari J.C., Wrin T., Berman P., Murthy K.K., and Powell M.F. Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response. J. Pharm. Sci. 87 (1998) 1489-1495
132. Richards Grayson A.C., Choi I.S., Tyler B.M., Wang P.P., Brem H., Cima M.J., and Langer R. Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat. Mater. 2 (2003) 767-772
133. Peppas N.A., Bures P., Leobandung W., and Ichikawa H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50 (2000) 27-46
134. Gupta P., Vermani K., and Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov. Today. 7 (2002) 569-579
135. Ishihara K., Kobayashi M., Ishimaru N., and Shinohara I. Glucose Induced Permeation Control of Insulin through a Complex Membrane Consisting of Immobilized Glucose Oxidase and a Poly(amine). Polymer J. 16 (1984) 625-631
136. Byrne M.E., Park K., and Peppas N.A. Molecular imprinting within hydrogels. Adv. Drug Deliv. Rev. 54 (2002) 149-161
137. Berner B., and Dinh S.M. Electronically Controlled Drug Delivery (1998), CRC Press, London, UK
138. Hafeli U.O. Magnetically modulated therapeutic systems. Int. J. Pharm. 277 (2004) 19-24
139. Ungaro F., Biondi M., Indolfi L., De Rosa G., La Rotonda M.I., Quaglia F., and Netti P.A. Bioactivated polymer scaffolds for tissue engineering. In: Ashammakai N., Rice R.L., and Sun W. (Eds). Topics in Tissue Engineering vol. II (2005). http://oulu.fi/spareparts/ebook_topics_in_t_e_vol2/index.html p. http://oulu.fi/spareparts/ebook_topics_in_t_e_vol2/index.html
140. Richardson T.P., Peters M.C., Ennett A.B., and Mooney D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19 (2001) 1029-1034
141. Chen R.R., Silva E.A., Yuen W.W., and Mooney D.J. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm. Res. 24 (2007) 258-264
142. Suciati T., Howard D., Barry J., Everitt N.M., Shakesheff K.M., and Rose F.R. Zonal release of proteins within tissue engineering scaffolds. J. Mater. Sci. Mater. Med. 17 (2006) 1049-1056
143. Ungaro F., Biondi M., d'Angelo I., Indolfi L., Quaglia F., Netti P.A., and La Rotonda M.I. Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics. J. Control Release. 113 (2006) 128-136
144. Whitesides G.M., Ostuni E., Takayama S., Jiang X., and Ingber D.E. Soft lithography in biology and biochemistry. Annu. Rev. Biomed. Eng. 3 (2001) 335-373
145. Hutmacher D.W., Sittinger M., and Risbud M.V. Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems. Trends Biotechnol. 22 (2004) 354-362
146. Hung A.M., and Stupp S.I. Simultaneous self-assembly, orientation, and patterning of peptide-amphiphile nanofibers by soft lithography. Nano. Lett. 7 (2007) 1165-1171
147. Wang D.A., Varghese S., Sharma B., Strehin I., Fermanian S., Gorham J., Fairbrother D.H., Cascio B., and Elisseeff J.H. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat. Mater. 6 (2007) 385-392
148. Reichenberger E., and Olsen B.R. Collagens as organizers of extracellular matrix during morphogenesis. Semin. Cell Dev. Biol. 7 (1996) 631-638
149. Ottani V., Martini D., Franchi M., Ruggeri A., and Raspanti M. Hierarchical structures in fibrillar collagens. Micron. 33 (2002) 587-596
150. Schwarz N. Biosynthesis and regulation of expression of proteoglycans. Front Biosci. (2000) D649-D655
151. Laurent T.C., and Fraser J.R. Hyaluronan. FASEB J. 6 (1992) 2397-2404
152. Lee J.Y., and Spicer A.P. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell Biol. 12 (2000) 581-586
153. Engel J. Laminins and other strange proteins. Biochemistry. 31 (1992) 10643-10651
154. Ruoslahti E., Pierschbacher M., Engvall E., Oldberg A., and Hayman E.G. Molecular and biological interactions of fibronectin. J. Invest Dermatol. 79 (1982) 65s-68s Suppl 1
155. Debelle L., and Alix A.J. The structures of elastins and their function. Biochimie. 81 (1999) 981-994
156. Flaumenhaft R., and Rifkin D.B. The extracellular regulation of growth factor action. Mol. Biol. Cell. 3 (1992) 1057-1065
157. Pachence J.M. Collagen-based devices for soft tissue repair. J. Biomed. Mater. Res. 33 (1996) 35-40
158. Battista S., Guarnieri D., Borselli C., Zeppetelli S., Borzacchiello A., Mayol L., Gerbasio D., Keene D.R., Ambrosio L., and Netti P.A. The effect of matrix composition of 3D constructs on embryonic stem cell differentiation. Biomaterials. 26 (2005) 6194-6207
159. Hudon V., Berthod F., Black A.F., Damour O., Germain L., and Auger F.A. A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br. J. Dermatol. 148 (2003) 1094-1104
160. Stark H.J., Boehnke K., Mirancea N., Willhauck M.J., Pavesio A., Fusenig N.E., and Boukamp P. Epidermal homeostasis in long-term scaffold-enforced skin equivalents. J. Investig. Dermatol. Symp. Proc. (2006) 93-105
161. Segura T., Anderson B.C., Chung P.H., Webber R.E., Shull K.R., and Shea L.D. Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials. 26 (2005) 359-371
162. Borselli C., Oliviero O., Battista S., Ambrosio L., and Netti P.A. Induction of directional sprouting angiogenesis by matrix gradients. J. Biomed. Mater. Res. A. 80 (2007) 297-305
163. Shi C., Zhu Y., Ran X., Wang M., Su Y., and Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J. Surg. Res. 133 (2006) 185-192
164. Lee J.E., Kim S.E., Kwon I.C., Ahn H.J., Cho H., Lee S.H., Kim H.J., Seong S.C., and Lee M.C. Effects of a chitosan scaffold containing TGF-beta1 encapsulated chitosan microspheres on in vitro chondrocyte culture. Artif. Organs. 28 (2004) 829-839
165. Ye Q., Zund G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., Hubbell J.A., and Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 17 (2000) 587-591
166. Jeon O., Ryu S.H., Chung J.H., and Kim B.S. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J. Control Release 105 (2005) 249-259
167. Okamoto T., Yamamoto Y., Gotoh M., Huang C.L., Nakamura T., Shimizu Y., Tabata Y., and Yokomise H. Slow release of bone morphogenetic protein 2 from a gelatin sponge to promote regeneration of tracheal cartilage in a canine model. J. Thorac. Cardiovasc. Surg. 127 (2004) 329-334
168. Ito A., Mase A., Takizawa Y., Shinkai M., Honda H., Hata K., Ueda M., and Kobayashi T. Transglutaminase-mediated gelatin matrices incorporating cell adhesion factors as a biomaterial for tissue engineering. J. Biosci. Bioeng. 95 (2003) 196-199
169. Day R.M., Boccaccini A.R., Maquet V., Shurey S., Forbes A., Gabe S.M., and Jerome R. In vivo characterisation of a novel bioresorbable poly(lactide-co-glycolide) tubular foam scaffold for tissue engineering applications. J. Mater. Sci. Mater. Med. 15 (2004) 729-734
170. Ng K.W., Hutmacher D.W., Schantz J.T., Ng C.S., Too H.P., Lim T.C., Phan T.T., and Teoh S.H. Evaluation of ultra-thin poly(epsilon-caprolactone) films for tissue-engineered skin. Tissue Eng. 7 (2001) 441-455
171. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., Metters A.T., Weber F.E., Fields G.B., and Hubbell J.A. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5413-5418
172. Holland T.A., Tabata Y., and Mikos A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J. Control Release. 101 (2005) 111-125
173. Paul W., and Sharma C.P. Ceramic drug delivery: a perspective. J. Biomater. Appl. 17 (2003) 253-264
174. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin. Orthop. Relat Res. (2002) 81-98
175. Horn E.M., Beaumont M., Shu X.Z., Harvey A., Prestwich G.D., Horn K.M., Gibson A.R., Preul M.C., and Panitch A. Influence of cross-linked hyaluronic acid hydrogels on neurite outgrowth and recovery from spinal cord injury. J. Neurosurg. Spine. 6 (2007) 133-140
176. Duflo S., Thibeault S.L., Li W., Shu X.Z., and Prestwich G.D. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng. 12 (2006) 2171-2180